SGHT Sight Sciences Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: SGHT

Price (delayed)

$5.96

Market cap

$295.34M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.14

Enterprise value

$191.14M

Highlights
Sight Sciences's EPS has increased by 37% YoY and by 10% from the previous quarter
The net income has grown by 36% YoY and by 10% from the previous quarter
The revenue is up by 14% YoY but it is down by 2.2% from the previous quarter
Sight Sciences's equity has decreased by 25% YoY and by 5% QoQ
Sector: Healthcare
Industry: Medical Devices
Peers: NVRO OFIX NURO

Key stats

What are the main financial stats of SGHT
Market
Shares outstanding
49.55M
Market cap
$295.34M
Enterprise value
$191.14M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
2.42
Price to sales (P/S)
3.58
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
2.36
Earnings
Revenue
$81.06M
EBIT
-$50.03M
EBITDA
-$48.41M
Free cash flow
-$47.98M
Per share
EPS
-$1.14
Free cash flow per share
-$0.99
Book value per share
$2.47
Revenue per share
$1.67
TBVPS
$3.43
Balance sheet
Total assets
$166.65M
Total liabilities
$46.44M
Debt
$33.93M
Equity
$120.22M
Working capital
$150.62M
Liquidity
Debt to equity
0.28
Current ratio
13.29
Quick ratio
12.44
Net debt/EBITDA
2.15
Margins
EBITDA margin
-59.7%
Gross margin
85.3%
Net margin
-68.5%
Operating margin
-70.7%
Efficiency
Return on assets
-30.6%
Return on equity
-41.9%
Return on invested capital
-100.2%
Return on capital employed
-32.4%
Return on sales
-61.7%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

SGHT stock price

How has the Sight Sciences stock price performed over time
Intraday
6.24%
1 week
12.88%
1 month
13.96%
1 year
-40.64%
YTD
15.5%
QTD
12.88%

Financial performance

How have Sight Sciences's revenue and profit performed over time
Revenue
$81.06M
Gross profit
$69.18M
Operating income
-$57.27M
Net income
-$55.55M
Gross margin
85.3%
Net margin
-68.5%
SGHT's net margin is up by 43% year-on-year and by 8% since the previous quarter
The operating margin is up by 40% year-on-year and by 7% since the previous quarter
The net income has grown by 36% YoY and by 10% from the previous quarter
SGHT's operating income is up by 32% year-on-year and by 9% since the previous quarter

Growth

What is Sight Sciences's growth rate over time

Valuation

What is Sight Sciences stock price valuation
P/E
N/A
P/B
2.42
P/S
3.58
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
2.36
Sight Sciences's EPS has increased by 37% YoY and by 10% from the previous quarter
Sight Sciences's equity has decreased by 25% YoY and by 5% QoQ
The stock's P/B is 5% more than its last 4 quarters average of 2.3
The revenue is up by 14% YoY but it is down by 2.2% from the previous quarter
The stock's price to sales (P/S) is 8% less than its last 4 quarters average of 3.9

Efficiency

How efficient is Sight Sciences business performance
The company's return on invested capital rose by 49% YoY and by 14% QoQ
Sight Sciences's ROS has increased by 46% YoY and by 9% from the previous quarter
The ROA is up by 17% year-on-year and by 4.4% since the previous quarter
The company's return on equity rose by 10% YoY and by 3.5% QoQ

Dividends

What is SGHT's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for SGHT.

Financial health

How did Sight Sciences financials performed over time
The total assets has contracted by 22% YoY and by 6% from the previous quarter
Sight Sciences's current ratio has increased by 13% YoY and by 10% QoQ
SGHT's debt is 72% smaller than its equity
SGHT's debt to equity is up by 33% year-on-year and by 3.7% since the previous quarter
Sight Sciences's equity has decreased by 25% YoY and by 5% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.